KV Pharmaceutical and Sandoz cough/cold product
Executive Summary
Long-term licensing agreement concluded for a once-daily cough/cold drug administered through KV's delivery technology KV/24. Cash payments, royalties and manufacturing revenues will be provided to KV. Other recent licensing agreements for KV include one with SS Pharmaceutical of Japan for Liquette stomach remedy developed by KV ("The Pink Sheet" Aug. 10, "In Brief") and with Taisho Pharmaceutical Ltd. of Japan for a once-a-day version of Japan's number one marketed cough/cold product ("The Pink Sheet" Oct. 5, "In Brief").